Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the …
Biotechnology
US, Waltham [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Syndax Pharmaceuticals, Inc. (SNDX) to it's peer group.
Peer Group
RVMD DICE KRTX PCVX CYTK AVTE CGEM COGT LRMR MRSN MLYS EWTX KALV STRO KROS VRDN DYN REPL INZY PLRX
Compare Together
Loading...